Terifrac injection uses :

• Postmenopausal osteoporosis
• Glucocorticoid-induced osteoporosis

Terifrac 750mcg injection, exerts a therapeutic effect by stimulating the formation of new bone tissue and increasing bone mineral density. By activating osteoblasts, the cells responsible for bone formation, it enhances bone strength, reduces fracture risk, and promotes bone healing. It offers significant benefits such as increased bone density, fracture risk reduction, improved quality of life, and serves as an alternative for individuals who have not responded well to other osteoporosis treatments.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with the Terifrac 750mcg injection, reducing effectiveness by causing undesirable side effects.

• Stored at controlled temperature, between 2-8°C.
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

Terifrac injection is typically administered by a healthcare professional. It is usually given as an injection. The healthcare provider will determine the terifrac injection dosage and duration of treatment based on the specific infection and individual factors.

Terifrac injection side effects like all medications, although not everyone will experience them. 

Serious:

• Hypercalcemia
• Allergic reactions that affect skin and breathing
• Skin reactions at the injection site include rashes, bruising, swelling, and itching
• Osteosarcoma (type of bone cancer)
• Hypercalcemia (increased level of calcium)
• Orthostatic hypotension (hypertension when stand after sitting or lying position)

Common:

• Arthralgia
• Nerve Pain
• Nausea
• Sickness
• Headache
• Dizziness
• Increased sweating
• Breathlessness
• Muscle cramps
• Increase in blood cholesterol levels
• Chest pain
• Burning sensation below the breast bone
• Anaemia

Prior to initiating Terifrac 750 mcg injection, it is crucial to disclose any preexisting medical conditions, particularly those related to bones or metabolism, as well as provide information about any medications or supplements being taken, to your healthcare professional. Extra care should be taken for individuals with a history of skeletal malignancies or bone metastases, as Terifrac 750mcg injection is not recommended in such cases. 

Regular monitoring of serum calcium levels is essential to identify and manage hypercalcemia. In patients with orthostatic hypotension or pre-existing hyperparathyroidism, Terifrac 750mcg injection should be used cautiously. The duration of treatment with this medication is generally limited, and its use is not advised in pediatric patients. If you are pregnant or breastfeeding, discussing the potential risks and benefits of Terifrac 750mcg injection with your healthcare provider before considering its use is crucial.

1. Eli Lilly and Company Limited, Electronic medicines compendium (EMC), [Revised on 06 Feb 2023], [Accessed on 1st June 2023], https://www.medicines.org.uk/emc/files/pil.3634.pdf
2. Eli Lilly and Company, US Food and Drug Administration, [Revised on September 2021],[Accessed on 1st June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021318Orig1s056lbl.pdf
3. KD Tripathi, Hormones and Drugs Affecting Calcium Balance, Essentials of Medical Pharmacology, 8th Edition, 2019, 360-372